Product Details for NDA 017895
JANIMINE (IMIPRAMINE HYDROCHLORIDE)
10MG
Marketing Status: Discontinued
25MG
Marketing Status: Discontinued
50MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
JANIMINE (IMIPRAMINE HYDROCHLORIDE)
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
25MG
Marketing Status: Discontinued
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
JANIMINE (IMIPRAMINE HYDROCHLORIDE)
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG
Marketing Status: Discontinued
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: JANIMINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017895
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information